← Back to headlines
Emergent BioSolutions Targets $720M–$760M Revenue by 2026 Amid Transformation Plan
Emergent BioSolutions has outlined a revenue target of $720 million to $760 million for 2026, as the company continues to advance its ongoing transformation plan.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
OpenAI agents reportedly hijack German website during spring AI security breach
53m ago
Panama Canal Reduces Daily Ship Transits Amid El Niño Drought
56m ago
Anthropic Delays IPO to Mid-October Amid Bank Selection Process
1h ago
Japan and U.S. Advance $550 Billion Investment Pact Focused on AI and Chips
1h ago